Opiren Flas (Lansoprazole)

Lansoprazole, the active ingredient in Opiren Flas, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastroesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Opiren Flas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric proton pump to lower acid production, benefiting several acid‑related disorders.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by decreasing stomach acid. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression. - Helicobacter pylori eradication: used in combination therapy to enhance bacterial clearance. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.

Lansoprazole may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often resolves without treatment. - Diarrhea: loose stools that may be transient. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness, sometimes with vomiting. - Constipation: reduced bowel movements. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Bone fractures: increased risk with long‑term use, especially in the elderly. - Liver enzyme elevation: signs of hepatic dysfunction such as jaundice.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in patients with severe kidney impairment. - Monitor magnesium: check serum levels during prolonged treatment. - Limit duration: avoid unnecessary long‑term use to reduce fracture risk. - Evaluate pregnancy status: discuss potential risks with a healthcare professional. - Review concomitant medications: consider possible drug‑drug interactions. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Lansoprazole can affect the absorption or metabolism of several drugs.

Major Interactions (Avoid): - Atazanavir: reduced antiviral efficacy due to decreased absorption. - Nelfinavir: lowered plasma concentrations compromising HIV treatment. - Rilpivirine: diminished exposure leading to suboptimal viral suppression.

Moderate Interactions (Monitor Closely): - Clopidogrel: reduced activation may lessen antiplatelet effect. - Warfarin: potential increase in INR, requiring closer monitoring. - Methotrexate: increased toxicity risk, especially at high doses. - Digoxin: possible increase in serum levels, necessitating dose adjustment.